Drugs obtained by biotechnology processing

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2011

Autores

Hugo Almeida (Autor) Outra; Maria Helena Amaral (Autor) FFUP; Paulo Lobao (Autor) FFUP

Revista

Título: Brazilian Journal of Pharmaceutical Sciences

Vol. 47 Nº 2

Páginas: 199-207

ISSN: 1984-8250

Editora: Universidade de São Paulo

Indexação

ISI Web of Knowledge - 1 Citação

Scopus - 3 Citações

Classificação Científica

FOS: Ciências médicas e da saúde > Medicina básica

Outras Informações

ID Authenticus: P-002-SGP

Abstract (EN): In recent years, the number of drugs of biotechnological origin available for many different diseases has increased exponentially, including different types of cancer, diabetes mellitus, infectious diseases (e.g. AIDS Virus / HIV) as well as cardiovascular, neurological, respiratory, and autoimmune diseases, among others. The pharmaceutical industry has used different technologies to obtain new and promising active ingredients, as exemplified by the fermentation technique, recombinant DNA technique and the hybridoma technique. The expiry of the patents of the first drugs of biotechnological origin and the consequent emergence of biosimilar products, have posed various questions to health authorities worldwide regarding the definition, framework, and requirements for authorization to market such products.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 9